Cordant, Inc. Amgen Inc Transaction History

Cordant, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	SELL	$230.71 - $256.74 $17,533 - $19,512	-76 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $16,664 - $18,435	76 New	76 $18,000
Q1 2020 Nov 18, 2020	SELL	$182.24 - $241.7 $12,756 - $16,919	-70 Closed	0 $0
Q4 2019 Nov 18, 2020	BUY	$189.21 - $243.2 $13,244 - $17,024	70 New	70 $17,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cordant, Inc., based on Form 13F filings with the SEC.

Stay updated on Cordant, Inc. with notifications on news.